Skip to main content
Premium Trial:

Request an Annual Quote

Volker Muschalek, Russell Bradley, Gregory Gosch, and more ...

Premium

Volker Muschalek, a member of MWG Biotech's management board for operations, human resources, IT, and India, resigned from his position this week, the company said.

Muschalek had served as the company's chief operating officer and had been co-managing the company with Wolfgang Pieken following the departure of board chairman Thomas Becker last year.


Russell Bradley has become vice president of business development and strategic planning of Luminex, the Austin, Texas-based company said last week. In addition, Gregory Gosch has become vice president of marketing and sales, and Randel Marfin vice president of the Luminex Bioscience Group, a new position.

Most recently, Bradley was director of Beckman Coulter's Cares initiative. He holds a BS in immunology and biochemistry from Monash University in Australia.


Roger Wiegand has become director of the infectious disease initiative at the Broad Institute, BioArray News has learned. Prior to joining the Broad, he was chief scientific officer of Cantata Laboratories in Cambridge, Mass.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.